US74765K1051
© BusinessWire
16.12.2025
QSI
LISTED
NASDAQ
Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a proteomics technology company redefining protein analysis through single-molecule detection, today announced that the Compensation Committee of Quantum-Si’s Board of Directors has granted 39,920 restricted stock units (“RSUs”) to new employees under the Company's previ...
Themefolio
Profiler
Peergroup
© BusinessWire
20.11.2025
QSI
LISTED
NASDAQ
Quantum-Si Highlights Significant Development Advancements for Proteus™ and Industry Leading Technology Pipeline at Investor & Analyst Day
News Preview
Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a proteomics technology company redefining protein analysis through single-molecule detection, today announced the highlights of its Investor & Analyst Day that was hosted in New York City on November 19, 2025.
Key Highlights:
Proteus™ platform on track for end...
Themefolio
Profiler
Peergroup
© BusinessWire
19.11.2025
QSI
LISTED
NASDAQ
Quantum-Si to Highlight Significant Proteus™ Platform Development Progress and Provide Insights into the Company’s Industry Leading Technology Pipeline at Investor & Analyst Day
News Preview
Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a proteomics technology company redefining protein analysis through single-molecule detection, today announced the key items to be presented at its Investor & Analyst Day that is being hosted in New York City.
Among other advances, the management team will provide...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© BusinessWire
05.11.2025
QSI
LISTED
NASDAQ
Quantum-Si Reports Third Quarter 2025 Financial Results
News Preview
Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a proteomics technology company redefining protein analysis through single-molecule detection, today announced financial results for the third quarter ended September 30, 2025.
Press Release Highlights
Reported revenue of $552,000 for the third quarter of 2025
An...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© BusinessWire
20.10.2025
QSI
LISTED
NASDAQ
Quantum-Si to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
News Preview
Quantum-Si Incorporated (Nasdaq: QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics technology company redefining protein analysis through single-molecule detection, today announced that it will be participating in the CG MedTech, Diagnostics and Digital Health & Services Forum taking place Thursday, November 20, 2025 at the Westin NY G...
Themefolio
Profiler
Peergroup
© BusinessWire
13.10.2025
QSI
LISTED
NASDAQ
Quantum-Si to Report Third Quarter 2025 Financial Results on November 5, 2025
News Preview
Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a proteomics technology company redefining protein analysis through single-molecule detection, today announced that it will report financial results for the third quarter 2025 on Wednesday, November 5, 2025. Jeff Hawkins, President and Chief Executive Officer, and Jeff K...
Themefolio
Profiler
Peergroup
© BusinessWire
23.09.2025
QSI
LISTED
NASDAQ
Quantum-Si to Host Investor & Analyst Event in New York City on November 19, 2025
News Preview
Quantum-Si Incorporated (Nasdaq: QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics technology company redefining protein analysis through single-molecule detection, today announced that the Company will host an Investor & Analyst event in New York City on November 19, 2025.
Key members of Quantum-Si’s management team will be present...
Themefolio
Profiler
Peergroup
© BusinessWire
15.09.2025
QSI
LISTED
NASDAQ
Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a proteomics technology company redefining protein analysis through single-molecule detection, today announced that the Compensation Committee of Quantum-Si’s Board of Directors has granted 17,033 restricted stock units (“RSUs”) to new employees under the Company’s previ...
Themefolio
Profiler
Peergroup
© BusinessWire
08.09.2025
QSI
LISTED
NASDAQ
Quantum-Si Announces the Launch of V4 Sequencing Kit, Expanding Proteome Coverage and Unlocking New Applications for Protein Sequencing
News Preview
Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a proteomics technology company redefining protein analysis through single-molecule detection, today announced the launch of the V4 Sequencing Kit. The new kit is compatible with both the Platinum® and Platinum® Pro instruments.
The V4 Sequencing Kit improves sequencin...
Themefolio
Profiler
Peergroup
© BusinessWire
19.08.2025
QSI
LISTED
NASDAQ
Quantum-Si to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
News Preview
Quantum-Si Incorporated (Nasdaq: QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics technology company redefining protein analysis through single-molecule detection, today announced that it will be participating in the H.C. Wainwright 27th Annual Global Investment Conference taking place at the Lotte New York Palace Hotel, September 8-10, 2...
Themefolio
Profiler
Peergroup
© BusinessWire
13.08.2025
QSI
LISTED
NASDAQ
Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a proteomics technology company redefining protein analysis through single-molecule detection, today announced that the Compensation Committee of Quantum-Si’s Board of Directors has granted 237,068 restricted stock units (“RSUs”) to new employees under the Company’s prev...
Themefolio
Profiler
Peergroup
© BusinessWire
21.07.2025
QSI
LISTED
NASDAQ
Quantum-Si to Participate in the Canaccord Genuity 45th Annual Growth Conference
News Preview
Quantum-Si Incorporated (Nasdaq: QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics technology company redefining protein analysis through single-molecule detection, today announced that it will be participating in the Canaccord Genuity 45th Annual Growth Conference taking place at the InterContinental Boston Hotel, August 12-14, 2025.
Je...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© BusinessWire
14.07.2025
QSI
LISTED
NASDAQ
Quantum-Si to Report Second Quarter 2025 Financial Results on August 5, 2025
News Preview
Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a proteomics technology company redefining protein analysis through single-molecule detection, today announced that it will report financial results for the second quarter 2025 on Tuesday, August 5, 2025. Jeff Hawkins, President and Chief Executive Officer, and Jeff Keye...
Themefolio
Profiler
Peergroup
© BusinessWire
04.07.2025
QSI
LISTED
NASDAQ
Quantum-Si Incorporated Announces Pricing of $50 Million Registered Direct Offering of Common Stock
News Preview
Quantum-Si Incorporated (Nasdaq: QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics technology company redefining protein analysis through single-molecule detection, today announced that it has entered into a securities purchase agreement with a single institutional investor for the purchase and sale of 29,940,119 shares of common stock (an...
Themefolio
Profiler
Peergroup
© BusinessWire
24.06.2025
QSI
LISTED
NASDAQ
Quantum-Si Platinum® Pro Instrument Placed at the Broad Institute to Support Regional Research Initiatives
News Preview
Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a proteomics technology company redefining protein analysis through single-molecule detection, today announced the placement of its Platinum® Pro instrument at the Broad Institute. This collaboration aims to support scientific innovation across oncology, therapeutics, an...
Themefolio
Profiler
Peergroup
© BusinessWire
19.06.2025
QSI
LISTED
NASDAQ
Quantum-Si to Join Leading Experts from DNAnexus, Olink, and Northwestern in Upcoming GenomeWeb Webinar on Proteomics Data Integration and Standardization
News Preview
Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a proteomics technology company redefining protein analysis through single-molecule detection, announces participation in an expert panel during the upcoming GenomeWeb-hosted webinar, "From Raw to Reusable: Considerations for Data Integration and Real-World Standardizati...
Themefolio
Profiler
Peergroup
© BusinessWire
17.06.2025
QSI
LISTED
NASDAQ
Quantum-Si Customer to Showcase Protein Barcoding for Nucleic Acid–LNP Therapeutic Development at Festival of Genomics Boston
News Preview
Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a proteomics technology company redefining protein analysis through single-molecule detection, announces a featured talk at the upcoming Festival of Genomics & Biodata Boson, highlighting innovative advances in protein sequencing technology for drug development.
Me...
Themefolio
Profiler
Peergroup
© BusinessWire
13.06.2025
QSI
LISTED
NASDAQ
Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a proteomics technology company redefining protein analysis through single-molecule detection, today announced that the Compensation Committee of Quantum-Si’s Board of Directors has granted 45,529 restricted stock units (“RSUs”) to new employees under the Company’s previ...
Themefolio
Profiler
Peergroup
© BusinessWire
10.06.2025
QSI
LISTED
NASDAQ
Quantum-Si’s Single-Molecule Tech Enables Precise, Multiplexed Measurement of Nanobody Binding in a Single Assay
News Preview
Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a proteomics technology company redefining protein analysis through single-molecule detection, announces a new preprint from researchers at Quantum-Si and ESPCI Paris that introduces a powerful method for measuring single-molecule binding kinetics at scale. The approach...
Themefolio
Profiler
Peergroup
© BusinessWire
15.05.2025
QSI
LISTED
NASDAQ
Quantum-Si Reports First Quarter 2025 Financial Results
News Preview
Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced financial results for the first quarter ended March 31, 2025.
Press Release Highlights
First quarter 2025 revenue of $842,000, an 84% increase over the first quarter of 2024
Launched and completed first deliveries of...
Themefolio
Profiler
Peergroup
© BusinessWire
13.05.2025
QSI
LISTED
NASDAQ
Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that the Compensation Committee of Quantum-Si’s Board of Directors has granted 16,555 restricted stock units (“RSUs”) to new employees under the Company’s previously adopted Quantum-Si Incorporated 2023 Inducement Equity I...
Themefolio
Profiler
Peergroup
© BusinessWire
12.05.2025
QSI
LISTED
NASDAQ
Dr. Gloria Sheynkman from the University of Virginia to Present Pioneering Research utilizing Quantum-Si’s Next-Gen Protein Sequencing™ Platform in Upcoming Nature Webinar on May 15
News Preview
Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, is pleased to announce an upcoming Nature webinar featuring Gloria Sheynkman, Ph.D., Associate Professor, University of Virginia, who will present new findings from her recent preprint on sequencing proteoform variation with Next-Gen Prot...
Themefolio
Profiler
Peergroup
© BusinessWire
24.04.2025
QSI
LISTED
NASDAQ
Quantum-Si to Report First Quarter 2025 Financial Results on May 15, 2025
News Preview
Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing CompanyTM, today announced that it will report financial results for the first quarter 2025 on Thursday, May 15, 2025. Jeff Hawkins, President and Chief Executive Officer, and Jeff Keyes, Chief Financial Officer, will host a conference call to disc...
Themefolio
Profiler
Peergroup
© BusinessWire
26.03.2025
QSI
LISTED
NASDAQ
Quantum-Si Begins Shipping Platinum® Pro, Advancing Accessibility in Next-Gen Protein Sequencing™
News Preview
Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, announces the start of shipments for its latest benchtop sequencer, Platinum® Pro. This groundbreaking instrument offers protein analysis with single-molecule precision, aiming to make Next-Gen Protein Sequencing™ more accessible to labor...
Themefolio
Profiler
Peergroup
© BusinessWire
24.03.2025
QSI
LISTED
NASDAQ
Quantum-Si to Participate in DNAnexus Webinar on Large Scale Proteomics in Multi-Omics Research
News Preview
Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, announces participation in an upcoming DNAnexus webinar focused on the role of proteomics in multi-omics research. This discussion will explore how the integration of proteomics data with other omics datasets is driving new discoveries in...
Themefolio
Profiler
Peergroup
© BusinessWire
20.03.2025
QSI
LISTED
NASDAQ
Quantum-Si to Participate in DNAnexus Webinar on Large Scale Proteomics in Multi-Omics Research
News Preview
Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, announces participation in an upcoming DNAnexus webinar focused on the role of proteomics in multi-omics research. This discussion will explore how the integration of proteomics data with other omics datasets is driving new discoveries in...
Themefolio
Profiler
Peergroup
© BusinessWire
13.03.2025
QSI
LISTED
NASDAQ
Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that the Compensation Committee of Quantum-Si’s Board of Directors has granted 20,833 restricted stock units (“RSUs”) to new employees under the Company’s previously adopted Quantum-Si Incorporated 2023 Inducement Equity I...
Themefolio
Profiler
Peergroup
© BusinessWire
03.03.2025
QSI
LISTED
NASDAQ
Quantum-Si Reports Fourth Quarter and Full Year 2024 Financial Results
News Preview
Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced financial results for the fourth quarter and full year ended December 31, 2024.
Press Release Highlights
Reported revenue of $1.2 million for the fourth quarter of 2024 and $3.1 million for the full year 2024 (represe...
Themefolio
Profiler
Peergroup
© BusinessWire
18.02.2025
QSI
LISTED
NASDAQ
Quantum-Si’s Customers and Researchers to Showcase Next-Generation Protein Sequencing™ at AGBT 2025
News Preview
Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, and several distinguished researchers will be presenting new research and applications at the 2025 Advances in Genome Biology and Technology (AGBT) General Meeting February 23-26th.
Quantum-Si, the pioneer in Next-Generation Protein Sequ...
Themefolio
Profiler
Peergroup
© BusinessWire
13.02.2025
QSI
LISTED
NASDAQ
Quantum-Si and Researchers to Showcase Next-Generation Protein Sequencing™ at US HUPO 2025
News Preview
Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, and several distinguished researchers will highlight advances in Next-Generation Protein Sequencing™ (NGPS™) at the US Human Proteome Organization’s 2025 conference in Philadelphia, Pennsylvania through a panel discussion and multiple pos...
Themefolio
Profiler
Peergroup
© BusinessWire
12.02.2025
QSI
LISTED
NASDAQ
Quantum-Si to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025
News Preview
Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that it will report financial results for the fourth quarter and full year 2024 on Monday, March 3, 2025. Jeff Hawkins, President and Chief Executive Officer, and Jeff Keyes, Chief Financial Officer, will host a conference...
Themefolio
Profiler
Peergroup
© BusinessWire
11.02.2025
QSI
LISTED
NASDAQ
Preprint from Northwestern University Highlights Complementary Proteomic Analysis of Interleukin-6 Using Next-Generation Protein Sequencing™ and Mass Spectrometry
News Preview
Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, announces a newly released preprint from researchers at Northwestern University, titled "Next-Generation Protein Sequencing and individual ion mass spectrometry enable complementary analysis of interleukin-6." The publication demonstrates...
Themefolio
Profiler
Peergroup
© BusinessWire
04.02.2025
QSI
LISTED
NASDAQ
Quantum-Si Establishes Scientific Advisory Board to Shape Next-Generation Proteomic Technologies
News Preview
Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, announces the formation of its Scientific Advisory Board. Comprised of distinguished experts in proteomics, genomics, bioinformatics, chemistry, and engineering, the board will play a critical role in shaping Quantum-Si’s scientific and d...
Themefolio
Profiler
Peergroup
© BusinessWire
28.01.2025
QSI
LISTED
NASDAQ
Quantum-Si and IDEX Health & Science to Partner on Optics Module for Proteus™ Instrument
News Preview
Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, and IDEX Health & Science, LLC., today announced they will partner on the development and manufacturing of the optics module for Quantum-Si’s novel proteomics platform, Proteus™.
IDEX Health & Science, LLC is the global leader i...
Themefolio
Profiler
Peergroup
© BusinessWire
20.01.2025
QSI
LISTED
NASDAQ
Quantum-Si Showcases Advances in Multiomics at the Festival of Genomics UK
News Preview
Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, announces its participation in the upcoming Festival of Genomics UK, taking place on January 29–30, 2025, at ExCeL London. As part of the event, Richard Broadhead, Ph.D., will deliver a presentation highlighting the latest innovations in...
Themefolio
Profiler
Peergroup
© BusinessWire
17.01.2025
QSI
LISTED
NASDAQ
Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that the Compensation Committee of Quantum-Si’s Board of Directors has granted 44,893 restricted stock units (“RSUs”) to new employees under the Company’s previously adopted Quantum-Si Incorporated 2023 Inducement Equity I...
Themefolio
Profiler
Peergroup
© BusinessWire
13.01.2025
QSI
LISTED
NASDAQ
Quantum-Si Launches Platinum® Pro: The End-to-End Solution for Deeper Insights in Proteomics
News Preview
Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, announces the launch of Platinum® Pro, its latest benchtop sequencer that sets a new standard in protein analysis. Designed to redefine efficiency and versatility in proteomics research, Platinum Pro is now available for ordering.
This p...
Themefolio
Profiler
Peergroup
© BusinessWire
08.01.2025
QSI
LISTED
NASDAQ
Quantum-Si’s New Preprint Showcases Protein Barcoding as a Powerful Tool for Transforming Proteomics
News Preview
Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, announces the release of its latest preprint titled “Protein Barcoding and Next-Generation Protein Sequencing for Multiplexed Protein Selection, Analysis, and Tracking.” This study highlights the potential of integrating Quantum-Si’s benc...
Themefolio
Profiler
Peergroup
© BusinessWire
03.01.2025
QSI
LISTED
NASDAQ
Quantum-Si Incorporated Announces Pricing of $50 Million Registered Direct Offering of Common Stock
News Preview
Quantum-Si Incorporated (Nasdaq: QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing Company™, today announced that it has entered into securities purchase agreements with certain institutional investors for the purchase and sale of 15,625,000 shares of common stock at a purchase price of $3.20 per share, pursuant to a registered d...
Themefolio
Profiler
Peergroup
© BusinessWire
20.12.2024
QSI
LISTED
NASDAQ
Quantum-Si’s New Preprint Showcases Advances in Protein Variant Detection using ProteoVue™ Software with Next-Generation Protein Sequencing™
News Preview
Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced a new paper that was submitted to BioRxiv, demonstrating the capabilities of its proprietary bioinformatics tool called ProteoVue, for detecting and quantifying Single Amino Acid Variants (SAAVs). The paper, titled “Detect...
Themefolio
Profiler
Peergroup
© BusinessWire
18.12.2024
QSI
LISTED
NASDAQ
Quantum-Si Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
News Preview
Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that the Compensation Committee of Quantum-Si’s Board of Directors has granted 46,666 restricted stock units (“RSUs”) to new employees under the Company’s previously adopted Quantum-Si Incorporated 2023 Inducement Equity I...
Themefolio
Profiler
Peergroup
© BusinessWire
12.12.2024
QSI
LISTED
NASDAQ
Quantum-Si Expands International Distribution Network
News Preview
Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, announced that it has expanded its international distribution network to a total of 15 partners.
The commercial distribution network includes further expansion across Western Europe, Eastern Europe and Asia, as well as new expansion int...
Themefolio
Profiler
Peergroup
© BusinessWire
04.12.2024
QSI
LISTED
NASDAQ
Quantum-Si Launches Platinum® New Library Prep Kit, Expanding Access to Next-Generation Protein Sequencing™
News Preview
Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, has introduced the Platinum Library Prep Kit, V2, an advanced tool for single-molecule protein sequencing that is designed to simplify workflows and expand researchers’ ability to analyze the proteome.
The new kit is designed to deliver...
Themefolio
Profiler
Peergroup
© BusinessWire
03.12.2024
QSI
LISTED
NASDAQ
Quantum-Si Introduces Protein Barcoding Kit for Multiplexed Protein Screening
News Preview
Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, has announced the launch of its protein Barcoding Kit designed to transform protein research by empowering researchers with an advanced multiplexed protein screening solution.
The protein Barcoding Kit offers a multiplexed solution for...
Themefolio
Profiler
Peergroup
© BusinessWire
21.11.2024
QSI
LISTED
NASDAQ
Quantum-Si Highlights Major Technical Advances, Next-Generation Platform Architecture and New Proteomic Applications at Investor & Analyst Event
News Preview
Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced the highlights of an Investor & Analyst event that was hosted in New York City on November 20th, 2024.
Quantum-Si’s Management team announced Platinum™ Pro, the Company’s evolution of Platinum, as well as Proteus™, t...
Themefolio
Profiler
Peergroup
© BusinessWire
20.11.2024
QSI
LISTED
NASDAQ
Avantor to Distribute Quantum-Si’s Next-Generation Protein Sequencing™ Technology
News Preview
Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, has announced a distribution agreement with Avantor® (NYSE: AVTR), a global leader in mission-critical products and services for the life sciences and advanced technology industries. Through this collaboration, Avantor will distribute Qua...
Themefolio
Profiler
Peergroup
© BusinessWire
20.11.2024
QSI
LISTED
NASDAQ
Quantum-Si to Develop Acceleration Platform and Advance Core Technologies in Collaboration with NVIDIA
News Preview
Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced a collaboration with NVIDIA to develop its new proteomics platform, Proteus™, and advance Quantum-Si’s core technologies of amino acid binders and aminopeptidases using NVIDIA AI and accelerated computing.
This collabora...
Themefolio
Profiler
Peergroup
© BusinessWire
20.11.2024
QSI
LISTED
NASDAQ
Quantum-Si Expands Collaboration with SkyWater to Develop New Chip Production Process Critical for Groundbreaking New Proteomics Platform
News Preview
Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™ and SkyWaterTechnology (NASDAQ: SKYT), the trusted technology realization partner, announced today they will jointly expand their relationship to support development of Proteus™, Quantum-Si’s next-generation platform designed to transform...
Themefolio
Profiler
Peergroup
© BusinessWire
20.11.2024
QSI
LISTED
NASDAQ
Quantum-Si and Planet Innovation to Partner on Proteus™
News Preview
Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, and Planet Innovation today announced that they will partner on the development and manufacturing of Quantum-Si’s novel proteomics platform, Proteus™.
Planet Innovation has a team of over four hundred people with expertise across design...
Themefolio
Profiler
Peergroup
© BusinessWire
18.11.2024
QSI
LISTED
NASDAQ
Quantum-Si Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
News Preview
Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that the Compensation Committee of Quantum-Si’s Board of Directors has granted 340,460 restricted stock units (“RSUs”) to a new employee under the Company’s previously adopted Quantum-Si Incorporated 2023 Inducement Equity...
Themefolio
Profiler
Peergroup
© BusinessWire
13.11.2024
QSI
LISTED
NASDAQ
Quantum-Si Honored with Frost & Sullivan’s 2024 Technology Innovation Leadership Award for Next-Generation Protein Sequencing™
News Preview
Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that it has been awarded Frost & Sullivan’s prestigious 2024 Technology Innovation Leadership Award in North America. This award recognizes QSI’s groundbreaking work in developing the Platinum® instrument, the first be...
Themefolio
Profiler
Peergroup
© BusinessWire
12.11.2024
QSI
LISTED
NASDAQ
Quantum-Si Reports Third Quarter 2024 Financial Results
News Preview
Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced financial results for the third quarter ended September 30, 2024.
Press Release Highlights
Reported revenue of $787,000 for the third quarter of 2024
Announced that Liberate Bio has integrated Platinum® Next-Genera...
Themefolio
Profiler
Peergroup
© BusinessWire
07.11.2024
QSI
LISTED
NASDAQ
University of Virginia Researchers Publish New Study on Tropomyosin Proteoforms Showcasing Quantum-Si’s Next-Gen Protein Sequencer™ Platinum®
News Preview
Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced a newly released preprint publication on BioRxiv, from Dr. Gloria Sheynkman at the University of Virginia School of Medicine. In the publication, Sheynkman and team demonstrate the application of Quantum-Si’s Platinum™ sin...
Themefolio
Profiler
Peergroup
© BusinessWire
05.11.2024
QSI
LISTED
NASDAQ
Quantum-Si to Participate in Upcoming Investment Conferences
News Preview
Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that it will be participating in two upcoming investment conferences.
Jeff Hawkins, Quantum-Si's Chief Executive Officer, will participate in a fireside chat discussion at the UBS Global Healthcare Conference on Wednesday...
Themefolio
Profiler
Peergroup
© BusinessWire
31.10.2024
QSI
LISTED
NASDAQ
Quantum-Si to Host Investor & Analyst Event in New York City on November 20th, 2024
News Preview
Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that the Company will host an Investor & Analyst event in New York City on November 20th, 2024.
Quantum-Si’s management team will provide updates on the Company’s evolving technology roadmap, emerging applications for...
Themefolio
Profiler
Peergroup
© BusinessWire
30.10.2024
QSI
LISTED
NASDAQ
Quantum-Si to Present at the 2024 American Society of Human Genetics Annual Meeting
News Preview
Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced its attendance at the 2024 American Society of Human Genetics (ASHG) Annual Meeting, where it will host a sponsored talk on the role of Next-Generation Protein Sequencing (NGPS) in advancing genomics research.
The present...
Themefolio
Profiler
Peergroup
© BusinessWire
23.10.2024
QSI
LISTED
NASDAQ
Quantum-Si to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024
News Preview
Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing CompanyTM, today announced that it will report financial results for the third quarter of 2024 on Tuesday, November 12, 2024. Company management will host a conference call to discuss financial results and provide a business update on the same day...
Themefolio
Profiler
Peergroup
© BusinessWire
17.10.2024
QSI
LISTED
NASDAQ
Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that the Compensation Committee of Quantum-Si’s Board of Directors has granted an aggregate of 385,983 restricted stock units (“RSUs”) to five new employees under the Company’s previously adopted Quantum-Si Incorporated 20...
Themefolio
Profiler
Peergroup
© BusinessWire
10.10.2024
QSI
LISTED
NASDAQ
Renowned Proteomic Researchers to Present Quantum-Si Data at World HUPO 2024
News Preview
Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced its participation at the Human Proteome Organization (HUPO) World Congress 2024 in Dresden, Germany. As a leader in Next-Generation Protein Sequencing™ (NGPS), Quantum-Si will be joined by prominent researchers to present...
Themefolio
Profiler
Peergroup
© BusinessWire
24.09.2024
QSI
LISTED
NASDAQ
Northwestern Proteomics Center of Excellence Partners with Quantum-Si for Webinar on Advancing Proteoform Analysis with Top-Down Mass Spectrometry and Single-Molecule Sequencing
News Preview
Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced an upcoming webinar that will explore the integration of top-down mass spectrometry (TD-MS) with Quantum-Si’s groundbreaking Platinum® instrument. The event, titled "Integrating Top-Down Mass Spectrometry and Single-Molecu...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
